Jiangsu Hengrui Medicine Co., Ltd.

This study tests a new drug, HRS-9190, against a standard muscle relaxant used during general anesthesia. About 60 adults having planned surgery will take part. The goal is to see how quickly muscle function returns after the drug is stopped, and to check for side effects.

This early-stage study tests a new drug called HRS-7172 in 120 adults with advanced solid tumors that have RAS mutations or amplifications. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. Researchers will also watch for signs …

This early-stage study tests a new injectable drug called SHR-3167 in 55 adults with type 2 diabetes. The goal is to measure how the drug behaves in the body and how well it controls blood sugar. Participants will be monitored for side effects and hypoglycemic events. The study i…

This study tests a new drug called FH-006 combined with other cancer treatments for people with advanced non-small cell lung cancer. The goal is to find the best dose and see if it helps shrink tumors. About 200 adults aged 18-75 with measurable tumors and good organ function can…

This study is testing a painkiller called bupivacaine liposome injection for children aged 6 to 17 after orthopedic (bone) surgery. The goal is to see if it safely controls pain and reduces the need for stronger opioid pain medicines. About 232 children will take part, and resear…